Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma

Gynecologic Oncology

Volumn 109, Issue 2, 2008, Pages 303-307

  Dowdy, Sean C ^a   Loewen, Ralitsa T ^a   Aletti, Giovanni ^a   Feitoza, Simone S ^a   Cliby, William ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cytoreductive surgery; Diaphragm; Ovarian carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DIAPHRAGM DISEASE; DIAPHRAGMATIC PERITONECTOMY; FEMALE; HUMAN; INTESTINE RESECTION; LIVER RESECTION; MAJOR CLINICAL STUDY; METASTASIS; OUTCOME ASSESSMENT; OVARY CARCINOMA; PERITONEUM PSEUDOMYXOMA; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RECURRENT CANCER; RETROSPECTIVE STUDY; SPLENECTOMY; SURGICAL TECHNIQUE; THORACOCENTESIS;

ADULT; AGED; CARCINOMA; DIAPHRAGM; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PERITONEUM; PLEURAL EFFUSION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 42749093591     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.02.012     Document Type: Article

References (28)

1. Aletti G.D., Dowdy S.C., Gostout B.S., Jones M.B., Stanhope C.R., Wilson T.O., et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 107 (2006) 77-85
2. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 (2002) 1248-1259
3. Griffiths C.T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42 (1975) 101-104
4. Ulfelder H., and Meigs J.V. The surgery of advanced pelvic cancer in women. N Engl J Med 246 (1952) 243-247
5. Eisenkop S.M., Spirtos N.M., Friedman R.L., Lin W.C., Pisani A.L., and Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 90 (2003) 390-396
6. Eisenkop S.M., Friedman R.L., and Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 69 (1998) 103-108
7. Aletti G.D., Gostout B.S., Podratz K.C., and Cliby W.A. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol 100 (2006) 33-37
8. Earle C.C., Schrag D., Neville B.A., Yabroff K.R., Topor M., Fahey A., et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 98 (2006) 172-180
9. Eisenhauer E.L., Abu-Rustum N.R., Sonoda Y., Levine D.A., Poynor E.A., Aghajanian C., et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 103 (2006) 1083-1090
10. Schwartz P.E., Chambers J.T., and Makuch R. Neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol 53 (1994) 33-37
11. Ansquer Y., Leblanc E., Clough K., Morice P., Dauplat J., Mathevet P., et al. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study. Cancer 91 (2001) 2329-2334
12. Bristow R.E., and Chi D.S. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol Oncol 103 (2006) 1070-1076
13. Merideth M.A., Cliby W.A., Keeney G.L., Lesnick T.G., Nagorney D.M., and Podratz K.C. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol 89 (2003) 16-21
14. Chen L.M., Leuchter R.S., Lagasse L.D., and Karlan B.Y. Splenectomy and surgical cytoreduction for ovarian cancer. Gynecol Oncol 77 (2000) 362-368
15. Eisenkop S.M., Spirtos N.M., and Lin W.C. Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer. Gynecol Oncol 100 (2006) 344-348
16. Magtibay P.M., Adams P.B., Silverman M.B., Cha S.S., and Podratz K.C. Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol 102 (2006) 369-374
17. Aletti G.D., Podratz K.C., Jones M.B., and Cliby W.A. Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer. J Am Coll Surg 203 (2006) 521-526
18. Eisenkop S.M. Thoracoscopy for the management of advanced epithelial ovarian cancer-a preliminary report. Gynecol Oncol 84 (2002) 315-320
19. Juretzka M.M., Abu-Rustum N.R., Sonoda Y., Downey R.J., Flores R.M., Park B.J., et al. The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. Gynecol Oncol 104 (2007) 670-674
20. Cliby W., Dowdy S., Feitoza S.S., Gostout B.S., and Podratz K.C. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol 94 (2004) 655-660
21. Aletti G.D., Dowdy S.C., Podratz K.C., and Cliby W.A. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 100 (2006) 283-287
22. Montz F.J., Schlaerth J.B., and Berek J.S. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer. Gynecol Oncol 35 (1989) 338-340
23. Silver D.F. Full-thickness diaphragmatic resection with simple and secure closure to accomplish complete cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 95 (2004) 384-387
24. Aletti G.D., Dowdy S.C., Gostout B.S., Jones M.B., Stanhope R.C., Wilson T.O., et al. Quality improvement (QI) in the surgical approach to advanced ovarian cancer: Mayo clinic experience. Presented at the Central Association of Obstetricians and Gynecologists, Chicago, IL (2007)
25. Chi D.S., Franklin C.C., Levine D.A., Akselrod F., Sabbatini P., Jarnagin W.R., et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 94 (2004) 650-654
26. Eisenkop S.M., and Spirtos N.M. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?. Gynecol Oncol 82 (2001) 435-441
27. Eisenkop S.M., and Spirtos N.M. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?. Gynecol Oncol 82 (2001) 489-497
28. Eisenhauer E.L., D'Angelica M.I., Abu-Rustum N.R., Sonoda Y., Jarnagin W.R., Barakat R.R., et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecol Oncol 103 (2006) 871-877